Tapping into the GLP-1 hype? Consider these pharma stocks.

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 30 sec. here
  • 5 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 63%

Michael Yee News

Eli Lilly,Market Domination,Biotech Companies

Enthusiasm for GLP-1 drugs on Wall Street persists, with Eli Lilly (LLY) committing more than $5.3 billion to expand a plant involved in the production of...

Jefferies Biotechnology Managing Director Michael Yee joins Market Domination to explain which biotech companies are hidden gems in the GLP-1 craze on Wall Street.) is one of the most important large-cap companies that we have been very bullish on. And they, too, will go to phase three with a monthly GLP-1. And we think the data is going to be great the end of the year.

We have said Amgen is one of the most important larger cap companies that we have been very bullish on and they too will go to phase three with a monthly G LP one.There's also smaller companies uh like Rock, uh SS Rrk or COR that also have new modalities um that are interesting.

We recently analyzed the top utilities stocks hedge funds are buying to profit from the AI-led boom in the industry. Since Vistra Corp. was part of the list, the stock deserves a deeper look. But first, let’s see why everyone’s taking about AI catalysts for utilities stocks these days.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in BUSİNESS

Business Business Latest News, Business Business Headlines